RAB11B-AS1: A Potential Drug Target and Biomarker for Multiple Sclerosis

Target Name: RAB11B-AS1

NCBI ID: G100507567

RAB11B-AS1

Other Name(s): MIR4999HG | RAB11B antisense RNA 1

RAB11B-AS1: A Potential Drug Target and Biomarker for Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by the immune system attacking the central nervous system, leading to a range of symptoms such as muscle weakness, vision loss, and cognitive impairment. Currently, there are limited treatment options available for MS patients, and the disease is often treated with supportive care and disease management strategies. However, new research has identified a potential drug target and biomarker for MS, named RAB11B-AS1.

The RAB11B-AS1 gene

RAB11B is a gene that encodes a protein known as Rab11B, which is a component of the endoplasmic reticulum (ER) and is involved in the transport of various proteins to the Golgi apparatus for degradation. The ER is a organell

Protein Name: RAB11B Antisense RNA 1

The "RAB11B-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RAB11B-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets